Postconditioning by xenon and hypothermia in the rat heart in vivo

European Journal of Anaesthesiology

Volumn 27, Issue 8, 2010, Pages 734-739

  Schwiebert, Christian ^a,b   Huhn, Ragnar ^a   Heinen, Andre ^a   Weber, Nina C ^a   Hollmann, Markus W ^a   Schlack, Wolfgang ^a   Preckel, Benedikt ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Anaesthetic gases; Cardiovascular system; Coronary occlusion; Heart; Infarction; Xenon

Indexed keywords

CHLORALOSE; DIAZEPAM; KETAMINE; TRIPHENYLTETRAZOLIUM; XENON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INDUCED HYPOTHERMIA; MALE; NONHUMAN; OXYGEN BREATHING; RAT; REPERFUSION INJURY;

ANIMALS; COMBINED MODALITY THERAPY; HEART; HYPOTHERMIA, INDUCED; MALE; MYOCARDIAL REPERFUSION INJURY; RANDOM ALLOCATION; RATS; RATS, WISTAR; TIME FACTORS; XENON;

EID: 77956814199     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e328335fc4c     Document Type: Article

References (25)

1. Wu E, Ortiz JT, Tejedor P, et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: Prospective cohort study. Heart 2008; 94:730-736.
2. Miller TD, Christian TF, Hopfenspirger MR, et al. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc Sestamibi imaging predicts subsequent mortality. Circulation 1995; 92:334-341.
3. Preckel B, Müllenheim J, Moloschavij A, et al. Xenon administration during early reperfusion reduces infarct size after regional ischemia in the rabbit heart in vivo. Anesth Analg 2000; 91:1327-1332.
4. Ma D, Hossain M, Chow A, et al. Xenon and hypothermia combine synergistically to provide neuroprotection from neonatal asphyxia. Ann Neurol 2005; 58:182-193.
5. Martin JL, Ma D, Hossain M, et al. Asynchronous administration of xenon and hypothermia significantly reduces brain infarction in the neonatal rat. Br J Anaesth 2007; 98:236-240.
6. Toma O, Weber NC, Wolter JI, et al. Desflurane preconditioning induces time-dependent activation of protein kinase C Epsilon and extracellular signal regulated kinase 1 and 2 in the rat heart in vivo. Anesthesiology 2004; 101:1372-1380.
7. Müllenheim J, Fräßdorf J, Preckel B, et al. Ketamine, but not S(+)-ketamine, blocks ischemic preconditioning in rabbit hearts in vivo. Anesthesiology 2001; 94:630-636.
8. Weber NC, Stursberg J, Wirthle NM, et al. Xenon preconditioning differentially regulates p44/42 MAPK (ERK1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo. Br J Anaesth 2006; 97:298-306.
9. Preckel B, Schlack W, Comfè re T, et al. Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo. Br J Anaesth 1998; 81:905-912. (Pubitemid 28561325)
10. Shao ZH, Chang WT, Chan KC, et al. Hypothermia-induced cardioprotection using extended ischemia and early reperfusion cooling. Am J Physiol Heart Circ Physiol 2007; 292:H1995-H2003.
11. Abella BS, Zhao D, Alvarado J, et al. Intra-arrest cooling improves outcomes in a murine cardiac arrest model. Circulation 2004; 109:2786-2791.
12. Baumert JH, Hein M, Gerets C, et al. The effect of xenon anesthesia on the size of experimental myocardial infarction. Anesth Analg 2007; 105:1200-1206.
13. Grosse Hartlage MA, Berendes E, Van Aken H, et al. Xenon improves recovery from myocardial stunning in chronically instrumented dogs. Anesth Analg 2004; 99:655-746.
14. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007; 357:1121-1135.
15. Zhao ZQ, Nakamura M, Wang NP, et al. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion. J Surg Res 2000; 94:133-144.
16. Pagel PS, Krolikowski JG, Shim YH, et al. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth Analg 2007; 105:562-569.
17. Deyhimy DI, Fleming NW, Brodkin IG, Liu H. Anesthetic preconditioning combined with postconditioning offers no additional benefit over preconditioning or postconditioning alone. Anesth Analg 2007; 105:316-324.
18. Müllenheim J, Ebel D, Bauer M, et al. Sevoflurane confers additional cardioprotection after ischemic late preconditioning in rabbits. Anesthesiology 2003; 99:624-631.
19. Huhn R, Heinen A, Schlack W, et al. Hyperglycaemia blocks sevofluraneinduced postconditioning in the rat heart in vivo: Cardioprotection can be restored by blocking the mitochondrial permeability transition pore. Br J Anaesth 2008; 100:465-471.
20. Chiari PC, Bienengraeber MW, Pagel PS, et al. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: Evidence for anestheticinduced postconditioning in rabbits. Anesthesiology 2005; 102:102-109.
21. Krolikowski JG, Bienengraeber M, Weihrauch D, et al. Inhibition of mitochondrial permeability transition enhances isoflurane-induced cardioprotection during early reperfusion: The role of mitochondrial KATP channels. Anesth Analg 2005; 101:1590-1596.
22. Huhn R, Heinen A, Weber NC, et al. Helium-induced late preconditioning in the rat heart in vivo. Br J Anaesth 2009; 102:614-619.
23. Tveita T, Skandfer M, Refsum H, Ytrehus K. Experimental hypothermia and rewarming: Changes in mechanical function and metabolism of rat hearts. J Appl Physiol 1996; 80:291-297.
24. Hale SL, Kloner RA. Myocardial temperature in acute myocardial, infarction: Protection with mild regional hypothermia. Am J Physiol Heart Circ Physiol 1997; 273:H220-H227.
25. Chien GL, Wolff RA, Davis RF, Van Winkle DM. 'Normothermic range' temperature affects myocardial infarct size. Cardiovasc Res 1994; 28:1014-1017.